Related Experiment Video
Updated: Nov 28, 2025

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
Published on: April 3, 2016
Risk factors for myopia at 1-year corrected age following laser photocoagulation for retinopathy of prematurity
Yujiro Mori1, Mitsuru Arima2, Emi Ueda1
1Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Insights
High laser spot counts during retinopathy of prematurity (ROP) treatment in preterm infants are linked to myopia development. This finding highlights a potential factor influencing visual outcomes in these vulnerable infants.
Area of Science:
- Ophthalmology
- Neonatology
- Pediatric Medicine
Background:
- Preterm infants undergoing laser photocoagulation (LPC) for retinopathy of prematurity (ROP) exhibit a higher prevalence of myopia.
- Understanding factors contributing to myopia in this population is crucial for early intervention and management.
Purpose of the Study:
- To investigate clinical factors associated with the development of myopia in preterm infants treated with LPC for ROP.
- To identify specific treatment-related variables that correlate with refractive errors in this high-risk group.
Main Methods:
- Retrospective analysis of medical records of preterm infants (≤32 weeks gestational age or ≤1500g birth weight) at Kyushu University Hospital (2008-2018).
- Multivariable linear regression was used to evaluate associations between nine clinical factors and the spherical equivalent (SE) at 1-year corrected age in infants treated with LPC for ROP.
- Refractive outcomes were assessed in 110 eyes of 56 infants.
Main Results:
- Of 485 infants, 76 developed ROP requiring treatment, with 71 undergoing LPC.
- The mean SE was -0.5 ± 3.0 diopters at 1-year corrected age.
- A significant association was found between a higher laser spot count and a more myopic SE (β = -0.081 ± 0.040 D per 100 spots, p=0.045).
Conclusions:
- Increased laser spot count during ROP treatment is associated with myopia in preterm infants.
- This finding suggests that the extent of laser treatment may be a modifiable factor influencing refractive outcomes.
- Further research is warranted to explore the mechanisms and clinical implications of this association.
Background/Objectives:
The prevalence of myopia is higher in preterm infants who underwent laser photocoagulation (LPC) for retinopathy of prematurity (ROP). The aim of this study was to investigate factors associated with myopia in preterm infants who undergo LPC for ROP.
Subjects/Methods:
We retrospectively analysed the medical records of preterm infants born at Kyushu University Hospital (October 2008-March 2018) at ≤32 weeks of gestational age or with birth weight ≤1500 g. We evaluated the associations between nine clinical factors and the spherical equivalent at 1-year corrected age by performing multivariable linear regression in LPC-treated ROP patients.
Results:
Among the 485 infants enroled, 76 developed ROP requiring treatment. Of these, 71 underwent LPC, which was provided to 63 infants as the primary treatment (LPC alone or the combination therapy of LPC and intravitreal injection of bevacizumab [IVB]) and to eight infants as additional LPC after IVB monotherapy. The results of a refractive examination at 1-year corrected age were available for 110 eyes of 56 infants (78.9%). The mean ± standard deviation of the SE value was -0.5 ± 3.0 dioptres (D). Multivariable linear regression analysis revealed a significant association between laser spot count and SE value (ß = -0.081 ± 0.040 D per 100 spots [mean ± standard error], p = 0.045).
Conclusions:
Our results suggest that an increased laser spot count observed during ROP treatment associates with myopia.
Related Concept Videos
Focusing of Light in the Eye
Photoreceptors and Visual Pathways
Glaucoma: Overview

